Drug intelligence / Profile preview

Regenaflex-K9

Development stage
Preclinical
Lead developer
Hilltop BioSciences
Administration
Intraarticular, Topical
01

Overview

Regenaflex-K9 is a veterinary regenerative biologic therapy developed by Hilltop BioSciences specifically for canine soft tissue and joint conditions. It is formulated as a bioscaffold material containing growth factors, cytokines, microRNA, and exosomes derived from amniotic sources, which deliver a cell-signaling cascade to reduce inflammation, promote tissue healing, support reparative tissue ingrowth, and minimize scarring. Administered via intra-articular injection or topical flex-Gel, it targets lameness from osteoarthritis, tendon/ligament/muscle injuries, non-healing wounds, and acute/chronic inflammation, offering consistent dosing, room-temperature stability, and rapid reconstitution compared to variable biologics like PRP or stem cells. Preliminary data from blinded studies show positive outcomes in canine osteoarthritis, with case reports demonstrating full soundness post-treatment.[1][2][3][4][5][8]

Brand names
Regenaflex-K9Regenaflex-K-9Regenaflex-K 9

Beyond the preview

Go deeper on Regenaflex-K9.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Regenaflex-K9.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call